心肺評估單元市場規模、佔有率和成長分析：按產品類型、應用、最終用戶、病患小組、便攜性、分銷管道和地區分類－2026-2033年產業預測

2024 年全球心肺評估設備市場價值為 158.04 億美元，預計到 2033 年將成長至 283.301 億美元，而 2025 年為 168.629 億美元，預測期（2026-2033 年）複合年成長率為 6.7%。

全球心肺評估設備（CRAU）市場涵蓋了先進的硬體和軟體解決方案，例如肺計量計、心肺運動試驗（CPET）系統以及旨在評估心肺健康相互關係的整合監測平台。該市場的發展動力源於慢性呼吸系統和心血管疾病盛行率的不斷上升，這些疾病需要精準診斷以改善治療策略並最大限度地減少再入院率。另一個關鍵促進因素是醫療模式轉向價值導向醫療的轉變，這要求醫療服務提供者利用能夠產生報銷計算所需數據的工具。需要即時心肺數據的遠距遠端醫療平台的日益普及進一步推動了市場成長。創新的攜帶式CPET設備使臨床醫生能夠制定個人化治療方案，最終改善患者預後並降低成本。同時，製造商也積極開發更小巧、更有效率的監測技術。

全球心肺評估設備市場的成長要素

全球心肺評估設備市場正受到輕型無線感測器和先進即時數據分析技術發展的巨大推動。這使得醫療專業人員能夠在床邊和社區直接進行全面的心肺功能評估，同時最大限度地減少對基礎設施的需求。這種更高的便攜性促進了各種醫療環境中的診斷服務，提高了評估設備的使用率，並增強了臨床效用和患者便利性。此外，易於部署的特性也促進了全球醫療網路中醫療機構的廣泛採用，簡化了員工培訓流程，並能無縫整合到現有工作流程中，最終推動了市場擴張。

全球心肺評估設備市場的限制因素

全球心肺評估設備市場面臨許多限制因素，主要原因是引進和安裝先進診斷設備的高成本。許多醫療機構，尤其是資源匱乏地區的機構，難以承擔投資新型感測器技術、專用軟體和必要基礎設施升級的巨額費用。這可能導致決策流程延長和預算緊張，甚至最終導致醫療機構放棄購買這些設備。相反，他們可能會採取選擇性策略，優先購買必要的設備，並將大規模投資推遲到價格和資金籌措方案更加優惠時再進行。此外，較長的投資回收期也會使管理人員的預算編制過程更加複雜和繁瑣。

心肺評估單元的全球市場趨勢

全球心肺評估設備市場正呈現出整合遠距遠端醫療解決方案的顯著趨勢，這將有助於改善患者照護和就醫途徑。醫療服務提供者正擴大將評估設備與遠端監測技術相結合，使患者能夠在舒適的家中有效地採集即時心肺指標。這種轉變減少了患者就醫次數，加快了異常情況的發現，並提高了護理的連續性，尤其對服務不足的人群而言更是如此。此外，製造商正致力於開發安全的資料傳輸方法和使用者友好的介面。與技術創新公司的合作以及標準化臨床指南的製定，正為保險公司降低成本和建立遠距心肺服務的最佳報銷模式鋪平道路。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球心肺評估設備市場規模：依產品類型分類

• 肺功能測試系統
• 心肺運動試驗系統
• 代謝評價系統
• 其他

全球心肺評估設備市場規模：依應用領域分類。

• 呼吸功能評估
• 心臟評估
• 綜合心肺功能評估

全球心肺評估設備市場規模：依最終用戶分類。

• 醫院
• 診斷中心
• 專科診所
• 其他

全球心肺評估設備市場規模：依病患小組分類

• 成年患者
• 兒童患者

全球心肺評估設備市場規模：依便攜性分類。

• 靜止系統
• 可攜式系統

全球心肺評估設備市場規模：按分銷管道分類

• 直銷
• 醫療設備銷售代理
• 其他

全球心肺評估設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• GE HealthCare Technologies Inc.
• Koninklijke Philips NV
• Nihon Kohden Corporation
• Schiller AG
• COSMED Srl
• MGC Diagnostics Corporation
• Vyaire Medical, Inc.
• CareFusion Corporation
• Hillrom Holdings, Inc.
• Masimo Corporation
• Mindray Medical International Limited
• Edan Instruments, Inc.
• Fukuda Denshi Co., Ltd.
• OSI Systems, Inc.
• Spacelabs Healthcare, Inc.
• InBody Co., Ltd.
• Geratherm Medical AG
• Morgan Scientific, Inc.
• Cortex Biophysik GmbH
• Cardinal Health, Inc.

結論與建議

Global Cardiorespiratory Assessment Units Market size was valued at USD 1580.4 Million in 2024 and is poised to grow from USD 1686.29 Million in 2025 to USD 2833.01 Million by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global market for Cardiorespiratory Assessment Units (CRAUs) encompasses advanced hardware and software solutions such as spirometers, cardiopulmonary exercise testing (CPET) systems, and integrated monitoring platforms designed to assess the interplay between cardiac and respiratory health. This market is propelled by the rising prevalence of chronic respiratory and cardiovascular conditions necessitating precise diagnostics to enhance treatment strategies and minimize hospital readmissions. A significant catalyst is the shift towards value-based care, urging providers to utilize tools yielding data essential for reimbursement. The growing integration of telehealth platforms demanding real-time cardiorespiratory data further fuels growth. Innovative portable CPET devices allow clinicians to tailor treatments, ultimately promoting better patient outcomes and cost reductions, while manufacturers respond by developing smaller, more efficient monitoring technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiorespiratory Assessment Units market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiorespiratory Assessment Units Market Segments Analysis

Global cardiorespiratory assessment units market is segmented by product type, application, end user, patient group, portability, distribution channel and region. Based on product type, no specific sub-segments were identified. Based on application, no specific sub-segments were identified. Based on end user, no specific sub-segments were identified. Based on patient group, no specific sub-segments were identified. Based on portability, no specific sub-segments were identified. Based on distribution channel, no specific sub-segments were identified. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiorespiratory Assessment Units Market

The Global Cardiorespiratory Assessment Units market is significantly driven by the development of lightweight wireless sensors and advanced real-time data analytics, enabling healthcare professionals to conduct comprehensive cardiorespiratory assessments directly at the bedside or within community environments with minimal infrastructure requirements. This enhanced portability facilitates diagnostic services across varied care settings, thus boosting the utilization of assessment units and enhancing both clinical utility and patient convenience. Furthermore, the ease of deployment encourages widespread institutional adoption within global healthcare networks, streamlining staff training processes and integrating seamlessly into existing workflows, ultimately propelling market expansion.

Restraints in the Global Cardiorespiratory Assessment Units Market

The Global Cardiorespiratory Assessment Units market faces significant constraints primarily due to the high costs associated with acquiring and installing advanced testing equipment. Many healthcare providers, particularly those in resource-limited environments, struggle with the financial implications of investing in new sensor technologies, specialized software, and necessary infrastructure upgrades. This can lead to extended decision-making processes and budgetary limitations, prompting institutions to potentially forgo purchasing these units altogether. Instead, they may opt to acquire essential equipment selectively, delaying larger investments until more favorable pricing or financing options arise. Additionally, the extended payback periods further complicate and lengthen the budgeting process for administrators.

Market Trends of the Global Cardiorespiratory Assessment Units Market

The Global Cardiorespiratory Assessment Units market is witnessing a significant trend towards integrated telehealth solutions that enhance patient care and accessibility. Healthcare providers are increasingly combining assessment units with remote monitoring technologies, enabling efficient collection of real-time cardiac and respiratory metrics from patients in their own homes. This shift minimizes hospital visits, accelerates anomaly detection, and improves continuity of care, particularly for underserved populations. Moreover, manufacturers are focused on developing secure data transmission methods and user-friendly interfaces. Collaborations with technology innovators and the establishment of standardized clinical guidelines are paving the way for insurers to realize cost savings and optimized reimbursement models for tele-cardiorespiratory services.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cardiorespiratory Assessment Units Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Pulmonary Function Testing Systems
• Cardiopulmonary Exercise Testing Systems
• Metabolic Assessment Systems
• Others

Global Cardiorespiratory Assessment Units Market Size by Application & CAGR (2026-2033)

• Market Overview
• Respiratory Assessment
• Cardiac Assessment
• Combined Cardiorespiratory Assessment

Global Cardiorespiratory Assessment Units Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Specialty Clinics
• Others

Global Cardiorespiratory Assessment Units Market Size by Patient Group & CAGR (2026-2033)

• Market Overview
• Adult Patients
• Pediatric Patients

Global Cardiorespiratory Assessment Units Market Size by Portability & CAGR (2026-2033)

• Market Overview
• Stationary Systems
• Portable Systems

Global Cardiorespiratory Assessment Units Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Medical Device Distributors
• Others

Global Cardiorespiratory Assessment Units Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End User, Patient Group, Portability, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, End User, Patient Group, Portability, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User, Patient Group, Portability, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User, Patient Group, Portability, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User, Patient Group, Portability, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE HealthCare Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COSMED Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGC Diagnostics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareFusion Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hillrom Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edan Instruments, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fukuda Denshi Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OSI Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spacelabs Healthcare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InBody Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geratherm Medical AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morgan Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cortex Biophysik GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations